|Publication number||US20040064110 A1|
|Application number||US 10/260,533|
|Publication date||Apr 1, 2004|
|Filing date||Oct 1, 2002|
|Priority date||Oct 1, 2002|
|Also published as||CA2498042A1, CN1703256A, CN1703256B, DE60335956D1, EP1545691A1, EP1545691B1, US7988616, US8821371, US20060127246, US20110282134, WO2004030745A1, WO2004030746A1|
|Publication number||10260533, 260533, US 2004/0064110 A1, US 2004/064110 A1, US 20040064110 A1, US 20040064110A1, US 2004064110 A1, US 2004064110A1, US-A1-20040064110, US-A1-2004064110, US2004/0064110A1, US2004/064110A1, US20040064110 A1, US20040064110A1, US2004064110 A1, US2004064110A1|
|Original Assignee||Peter Forsell|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (12), Classifications (16), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
 The present invention relates to an injection port and an implantable pump for adding fluid to, or withdrawing fluid from, a surgical implant inside a human body. The present invention also relates to surgical methods for treating diseases using the injection port and pump.
 Traditional so called injection ports are used for post-operation adjustments of hydraulic implants. The injection port comprises a thick wall member of silicone mounted under tension to create a membrane through which it is possible to inject a specific type of needle for injecting hydraulic fluid into the interior of the port, without afterwards creating leakage through the membrane. The needle has a lateral opening and does not cut out any remaining hole in the silicone membrane. It just moves the silicone aside. The silicone membrane of traditional injection ports comprises a relatively hard (typically a hardness of about 60 Shore) and thick solid silicone. Since the thickness of the membrane normally is about 6 mm for a normal-sized injection port, it is difficult to find a proper location in the patient for subcutaneous implantation of the injection port. Besides, traditional injection ports are not suited for hydraulically adjustable implants that need to be adjusted frequently, i.e., several times a day.
 An object of the present invention is to provide an injection port and an implantable pump, which are thinner and smaller than those of the prior art, and, therefore, more easily implanted subcutaneously. Another object of the present invention is to provide an injection port and an implantable pump, which are more versatile than those of the prior art. A further object of the present invention is to provide an injection port and an implantable pump that are easy and cheap to manufacture. Yet another object of the present invention is to provide surgical methods by using an injection port.
 Accordingly, in accordance with a first aspect of the present invention, there is provided an injection port for adding fluid to, or withdrawing fluid from, a surgical implant inside a human body, the injection port comprising a rigid base member, and an injection membrane attached to the base member, the membrane and the base member defining a chamber for fluid, wherein the membrane includes a first layer and a second layer attached to each other, the first layer having better strength properties than the second layer and the second layer having better sealing properties than the first layer.
 As a result, the thickness of the membrane may even be halved in comparison to the membrane used in prior injection ports. For example, the thickness of the membrane of the injection port of the present invention may be as small as about 3 mm. Furthermore, if the membrane is designed with a shorter diameter, it can be even thinner. Thus, since the thickness of the membrane can be substantially decreased in comparison to prior art, the injection port of the present invention can also be designed to be small and thin.
 Another advantage obtained by the injection port of the present invention is that it also works as a small pump, which can be manually operated.
 The membrane layers of the present invention may be made of silicone, wherein the first silicone layer is harder than the second silicone layer. The second layer silicone suitably has a hardness less than 20 Shore. Generally, the second layer is situated between the first layer and the chamber of the injection port. Alternatively, the membrane may comprise a third layer harder than the second layer, wherein the third layer is situated between the second layer and the chamber.
 The membrane is suitably displaceable, preferably manually, relative to the base member between a first position, in which the volume of the chamber is maximal, and a second position, in which the volume of the chamber is minimal. The membrane is preferably elastic and may take the shape of a semi-sphere, when it is in the first position. Accordingly, when the membrane is displaced to the second position it is substantially flattened and in a state of tension.
 The injection port may further comprise a locking device adapted to releaseably lock the membrane in the second position. Thus, the membrane may be displaced from the first position to the second position by manually depressing the membrane. Moreover, the locking device can be adapted to release the membrane from the second position upon pushing the membrane, whereby the membrane resumes its semi-spherical shape in the first position.
 In accordance with a second aspect of the present invention, there is provided an implantable pump for pumping fluid to and from a surgical implant inside a human body, comprising a rigid base member, and an injection membrane penetrable by an injection needle and attached to the base member, the membrane and the base member defining a chamber for fluid, wherein the membrane is displaceable relative the base member between a first position, in which the volume of the chamber is maximal, and a second position, in which the volume of the chamber is minimal, whereby the amount of fluid that is to be pumped between the chamber and the surgical implant can be calibrated by inserting an injection needle through the injection membrane and adding fluid to or withdrawing fluid from the chamber.
 The injection membrane of the implantable pump may be designed as the membrane discussed above in connection with the injection port of the invention
 In accordance with a third aspect of the present invention, there is provided a method for hydraulically operating a surgical implant implanted in a patient, the method comprising: subcutaneously implanting in the patient an injection port having a displaceable injection membrane for changing the volume of a fluid chamber in the injection port; hydraulically connecting the injection port to the surgical implant; calibrating the amount of fluid in the fluid chamber of the injection port by penetrating the patient's skin and the membrane of the injection port with an injection needle and adding fluid to or withdrawing fluid from the fluid chamber; and from time to time, manually displacing the membrane of the subcutaneously implanted injection port, in order to distribute fluid between the fluid chamber of the injection port and the implant to operate the implant.
 In accordance with a fourth aspect of the present invention, there is provided a surgical method for treating a patient having a disease, comprising the steps of: insufflating the patient's abdomen with gas; placing at least two laparoscopical trocars in the human's body; inserting at least one dissecting tool through the trocars and dissecting a region of the patient; implanting an implant designed for treating reflux disease, urinary incontinence, impotence, anal incontinence or obesity, in the dissected area by using surgical instruments through the trocars; subcutaneously implanting in the patient an injection port having a displaceable injection membrane for changing the volume of a fluid chamber in the injection port; hydraulically connecting the injection port to the surgical implant; calibrating the amount of fluid in the fluid chamber of the injection port by penetrating the patient's skin and the membrane of the injection port with an injection needle and adding fluid to or withdrawing fluid from the fluid chamber; and from time to time, manually displacing the membrane of the subcutaneously implanted injection port, in order to distribute fluid between the fluid chamber of the injection port and the implant to operate the implant.
 The above described apparatuses and methods may also be designed for treating reflux disease, urine incontinence, impotence, anal incontinence or obesity or the like.
 A preferred embodiment of the present invention will now be described by way of example, with reference to the attached drawings, by no way restricting the present invention thereto, wherein
FIG. 1 shows an injection port according to the prior art.
FIG. 2 illustrates an injection port according to the present invention, where a needle has been injected through the membrane.
FIG. 3 shows the injection port of FIG. 2 working as a hand driven pump.
FIG. 4 shows the injection port of FIG. 2 working as a hand driven pump, where the membrane is in its lowest position.
FIG. 5 is a schematic view of an implantable hydraulic restriction device for use together with the injection port of the invention, designed for treating reflux disease, urine incontinence, anal incontinence or obesity.
FIG. 1 shows a traditional injection port 1 according to the prior art, which has a housing 2 mounted on a base 3 and a membrane 4 made of solid silicone covering an opening in housing 2. Typically, the silicone used to make membrane 4 has a hardness of 60 Shore or more. The thickness of membrane 4 is normally about 6 mm for a normal-sized injection port.
FIG. 2 shows an injection port 10 according to the present invention, where a needle 12 of a syringe 14 has been injected through a membrane 16 attached to a rigid base member 18 of the injection port 10. According to the embodiment shown in FIG. 2, membrane 16 has a semi-spherical shape in its initial, “non-depressed” position, as shown in FIG. 2. In the embodiment shown in FIGS. 2-4, membrane 16 is comprised of three layers attached to each other: a first hard layer 20 having preferably a hardness of more than 20 Shore; a second soft central layer 22 having a hardness of less than 20 Shore; and a third hard layer 24, having a hardness suitably more than 20 Shore, but preferably about 60 Shore or more. Membrane 16 and base member 18 define a chamber 25 for fluid. However, in the most general embodiment of the injection port of the present invention, it is sufficient if membrane 16 comprises two layers, i.e., one first hard layer and one second soft layer between chamber 25 and first layer 20. First layer 20 has better strength properties than second layer 22, and second layer 22 has better sealing properties than first layer 20. Membrane 16's layers are suitably made of plastic or silicone, and preferably of silicone. Suitable silicon materials are manufactured by “Applied Silicone, Inc.”
FIGS. 3 and 4 show injection port 10 of FIG. 2 working as a hand driven pump. By using a core for membrane 16 that is very soft, i.e., elastic silicone material of less than 20 shore, it is possible to create a thinner and more elastic membrane that could be pumped by hand and still not cause leakage when a needle 12 of a syringe 14 penetrates the membrane. FIG. 3 illustrates a finger 26 pushing (actuated by one push) membrane 16 in a direction 28 from above. Membrane 16 will then be substantially flattened, such that the surface that is faced against the finger 26 will assume a somewhat concave bowl-shape 30. Membrane 16 is then moved to a lowest position, as shown in FIG. 4, where it is held by a locking device 32 until it is manually pressed again. When membrane 16 is actuated again, by a second push by the finger 26, the locking device 32 (which functions similar to the locking mechanism for a ballpoint pen) releases membrane 16, whereby membrane 16 is able to return to its regular convex-shaped condition as shown in FIG. 2.
FIG. 5 shows an example of an implantable hydraulic restriction device 41 comprising a band 40 formed into a loop around a patient's rectum (not shown), so that restriction device 41 may function as an artificial sphincter. Band 40 includes a cavity 42, which can be hydraulically connected to an injection port 10 of the invention. By using injection port 10, hydraulic fluid may be supplied to band 40 to inflate cavity 42, in order to close the rectum, and be withdrawn from the band 40 to deflate the cavity 42, to open the rectum. This type of restriction device, when combined with injection port 10 of the present invention, may also be used as an artificial sphincter for treating patients suffering from heartburn and reflux disease or urinary incontinence. Restriction device 41 may also be combined with injection port 10 for the purpose of forming an adjustable constricted stoma opening in the stomach or esophagus of an obese patient to treat obesity or for restricting the penile exit blood flow of an impotent patient.
 According to the method of using injection port 10 to treat various diseases, after injection port 10 is subcutaneously implanted in the patient, displaceable injection membrane 16 is used to pump fluid in fluid chamber 25 to surgical implanted restriction device 41, which is hydraulically connected to injection port 10. The amount of fluid in fluid chamber 25 capable of being pumped to restriction device 41 using injection port 10 is calibrated by penetrating the patient's skin and membrane 16 of injection port 10 with injection needle 12 of syringe 14 to add or withdraw fluid from chamber 25. Membrane 16 is manually displaced from time to time to pump the fluid from chamber 25 of injection port 10 to implant 41 to operate the implant.
 To insert in a patient an implant-like hydraulic restriction device 41, the patient's abdomen is insufflated with gas, after which at least two laparoscopical trocars are placed in the patient's body. At least one dissecting tool is then inserted through the trocars to dissect a region of the patient to implant in the dissected area using surgical instruments through the trocars the particular implant that is designed for treating the particular disease to be treated.
 Although the present invention has been described in terms of a particular embodiment and process, it is not intended that the invention be limited to that embodiment. Modifications of the embodiment and process within the spirit of the invention will be apparent to those skilled in the art. The scope of the invention is defined by the claims that follow.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7785302||Mar 6, 2006||Aug 31, 2010||C. R. Bard, Inc.||Access port identification systems and methods|
|US7828715||Jun 30, 2006||Nov 9, 2010||Ams Research Corporation||Method of treating anal incontinence|
|US7850666||Jan 19, 2006||Dec 14, 2010||Medical Components, Inc.||Catheter infusion port|
|US7947022||Apr 7, 2009||May 24, 2011||C. R. Bard, Inc.||Access port identification systems and methods|
|US8371998||Sep 28, 2010||Feb 12, 2013||American Research Corporation||Method of treating anal incontinence|
|US8622888 *||Dec 21, 2006||Jan 7, 2014||Wolfgang Lechner||System for controlling a controllable stomach band|
|US8801593||Jan 22, 2013||Aug 12, 2014||Ams Research Corporation||Method of treating anal incontinence|
|US9044298||Aug 23, 2011||Jun 2, 2015||Apollo Endosurgery, Inc.||Self-adjusting gastric band|
|US9079004||Nov 1, 2010||Jul 14, 2015||C. R. Bard, Inc.||Overmolded access port including anchoring and identification features|
|US9089395||Nov 16, 2011||Jul 28, 2015||Appolo Endosurgery, Inc.||Pre-loaded septum for use with an access port|
|US20140079741 *||Mar 19, 2012||Mar 20, 2014||Katholieke Universiteit Leuven Ku Leuven Research & Development||Inhibition and treatment of biofilms|
|WO2012125698A1||Mar 14, 2012||Sep 20, 2012||Allergan, Inc.||Self-adjusting gastric band having various compliant components and/or satiety booster|
|International Classification||A61M5/142, A61M39/02|
|Cooperative Classification||A61M5/14276, A61M2039/0054, A61M2039/0072, A61M5/1428, A61M39/0208, F04B9/14, F04B43/0063, F04B43/04|
|European Classification||F04B43/04, F04B9/14, F04B43/00D8B, A61M5/142P10M, A61M39/02B|
|Dec 19, 2002||AS||Assignment|
Owner name: POTENCIA MEDICAL AG, SWITZERLAND
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FORSELL, PETER;REEL/FRAME:013594/0347
Effective date: 20021217